|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 84.84 USD | -0.01% |
|
+0.18% | +82.26% |
| 08-28 | Crinetics Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
| 08-04 | Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says | MT |
| Market Cap | 9B 7.77B 7.28B 6.65B 12.51B 858B 12.57B 86.31B 33.7B 434B 33.78B 33.05B 1,440B | P/E 2026 * |
-18.2x | P/E 2027 * | -20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 7.99B 6.9B 6.47B 5.91B 11.11B 762B 11.17B 76.67B 29.93B 386B 30.01B 29.35B 1,279B | EV / Sales 2026 * |
104x | EV / Sales 2027 * | 46.3x |
| Free-Float |
98.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Crinetics Pharmaceuticals, Inc.
| 1 day | -0.01% | ||
| 1 week | +0.18% | ||
| Current month | +1.58% | ||
| 1 month | +1.17% | ||
| 3 months | +135.60% | ||
| 6 months | +106.42% | ||
| Current year | +82.26% |
| 1 week | 84.71 |  | 84.88 |
| 1 month | 83.47 | | 84.88 |
| Current year | 32.3 | | 84.88 |
| 1 year | 31 | | 84.88 |
| 3 years | 15.76 | | 84.88 |
| 5 years | 15.23 | | 84.88 |
| 10 years | 10.63 | | 84.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/20/26 | Free | Chief Financial Officer | 471 | 0.0004% | ||
| 8/7/26 | Fiscal year | Founder | 39,856 | 0.0378% | ||
| 7/2/26 | Sell | Director | -3,000 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | +0.18% | +176.80% | +398.18% | 9B | |
| -1.59% | -3.35% | +64.49% | +98.69% | 69.54B | |
| -1.34% | -0.75% | +48.56% | +90.63% | 64.97B | |
| -8.37% | -12.43% | +0.14% | -15.42% | 25.64B | |
| -2.35% | -5.75% | -12.17% | +448.29% | 25.89B | |
| +0.30% | -0.69% | +63.18% | +11.93% | 26.51B | |
| -0.96% | +10.36% | +278.86% | +438.78% | 20.22B | |
| -0.51% | +0.23% | +33.71% | -18.02% | 19.98B | |
| -1.91% | -4.37% | +13.33% | +531.29% | 15.69B | |
| -1.47% | +0.68% | +43.67% | +145.49% | 13.49B | |
| Average | -1.82% | -1.72% | +71.06% | +212.98% | 29.09B | |
| Weighted average by Cap. | -1.87% | -1.45% | +60.85% | +160.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 76.86M 66.36M 62.2M 56.79M 107M 7.33B 107M 737M 288M 3.71B 289M 282M 12.3B | 180M 156M 146M 133M 251M 17.21B 252M 1.73B 676M 8.7B 677M 663M 28.88B |
| Net income | -507M -438M -411M -375M -705M -48.4B -709M -4.87B -1.9B -24.47B -1.91B -1.86B -81.21B | -463M -400M -375M -342M -644M -44.2B -647M -4.45B -1.74B -22.35B -1.74B -1.7B -74.17B |
| Net Debt | -1.01B -868M -814M -743M -1.4B -95.9B -1.4B -9.64B -3.77B -48.49B -3.77B -3.69B -161B | -647M -559M -524M -478M -899M -61.71B -904M -6.21B -2.42B -31.2B -2.43B -2.38B -104B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | US$84.84 | -0.01% | 1,127,886 |
| 26-08-27 | US$84.85 | +0.01% | 1,058,995 |
| 26-08-26 | US$84.84 | -0.02% | 479,524 |
| 26-08-25 | US$84.86 | +0.09% | 1,241,641 |
| 26-08-24 | US$84.78 | +0.11% | 908,510 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
